The Super Bowl is no longer just America’s biggest sporting event — it’s the most expensive billboard in the world, and in 2026, Big Tech and Big Pharma just bought every inch of it. What gets sold during those four hours shapes public perception of entire industries. And this year, AI and weight-loss drugs didn’t just show up — they dominated.
Super Bowl LIX delivered exactly what the ad industry promised: wall-to-wall celebrity cameos, AI-powered pitches, and weight-loss drug spots that made pharmaceutical advertising feel almost aspirational. It was a spectacle designed to make you feel like the future is already here — polished, convenient, and endorsed by someone famous enough that you won’t ask hard questions about it.
The Celebrity-Tech Pipeline Is Running Hot
Here’s what actually happened on that screen: celebrities lent their faces to tech startups and established AI platforms alike, trading cultural capital for a check and a brand halo. This isn’t new. But the scale in 2026 is different. AI companies aren’t just running ads anymore — they’re running campaigns with the same emotional architecture as Nike spots from the ’90s. They want you to feel something. They want association, not explanation.
That’s a red flag dressed up as a highlight reel.
When a startup pays $7 million for 30 seconds and spends half of it on a celebrity’s face rather than what the product actually does, you’re watching a confidence trick in real time. The product isn’t being sold. The vibe is. And in 2026, the vibe is: AI is safe, friendly, inevitable, and celebrity-approved.
What the Weight-Loss Drug Ads Tell Us About Tech’s Real Competition
The GLP-1 drug companies — think Ozempic adjacents and their fast-growing telehealth delivery platforms — ran some of the most polished tech-adjacent ads of the night. These aren’t just pharma plays anymore. They’re health-tech plays. The apps, the subscriptions, the data collection, the personalized dosing algorithms — this is where the real money is heading.
Watch where the celebrity tech crossover lands next. It’s not just AI assistants and cloud storage. It’s body optimization platforms with slick UX and monthly fees. The lines between health, tech, and lifestyle are blurring fast. General-purpose AI is already outperforming specialized clinical tools on medical benchmarks — so don’t be shocked when your weight-loss app starts making decisions your GP used to make.
AI Ads in 2026: Confidence Without Accountability
The AI ads were something else entirely. Glossy. Warm. Reassuring in a way that should make anyone who covers this space deeply uncomfortable. These companies are selling trust before they’ve earned it. They’re borrowing credibility from celebrities who almost certainly have not read a single terms-of-service document related to the product they’re endorsing.
There were demos that felt closer to magic shows than product reveals. Features presented as live that were almost certainly curated. Scenarios designed to look effortless. The subtext in every frame: don’t worry about how this works, just know that it does.
Meanwhile, the actual risk profile of AI in 2026 is anything but reassuring. AI is actively speeding up cybercrime by exposing system vulnerabilities faster than defenders can patch them. But you won’t see that in a Super Bowl spot. You’ll see a smiling celebrity asking their AI to plan dinner and being delighted by the result.
The Startup Angle Nobody Is Talking About
Buried inside the spectacle are the real stories. Several of the AI companies that ran spots this year are less than four years old. A few have never turned a profit. One is currently facing regulatory scrutiny in the EU. They spent millions on 30-second slots to manufacture legitimacy because legitimacy is exactly what they don’t yet have.
That’s not criticism for criticism’s sake. That’s just what’s happening. The Super Bowl has always been a place where companies go to become real in the public imagination. In previous decades it was dot-coms spending venture money on sock puppet mascots. Today it’s AI platforms spending venture money on A-list faces. The math hasn’t changed. The hype cycle is just faster and the stakes are higher.
If you want to see where this energy eventually lands when it gets serious — when the hype has to justify itself — look at what serious tech ecosystems are building away from the ad budget noise. The kind of work being shown at events like Paris VivaTech tells a different story from what aired last Sunday night. Less celebrity. More substance.
The Hot Take
Celebrity tech endorsements should be regulated the same way financial advice is. If a former athlete or pop star is putting their name behind an AI product, a health-tech platform, or a startup that handles your personal data, there should be a legal disclosure standard — not just an asterisk. The FTC is decades behind on this. By the time regulators catch up, an entire generation will have been sold products they don’t understand by people paid not to understand them either.
Super Bowl LIX was a mirror held up to the tech industry in 2026 — and what it reflected was an industry more interested in being liked than being trusted. The real work of building reliable, honest, accountable technology doesn’t come with a soundtrack and a celebrity cameo. It comes with transparency, hard tradeoffs, and products that hold up when the lights go down and the crowd goes home. The companies that understand that distinction are the ones worth watching. The ones that bought airtime last Sunday? Watch them carefully, but watch your wallet too.